What is the appropriate management for an acute viral upper‑respiratory infection presenting with sore throat, rhinorrhea, fever, and productive cough?

Management of Acute Viral Upper Respiratory Infection

This is a viral upper respiratory infection that requires symptomatic treatment only—antibiotics are not indicated and should not be prescribed. 1, 2

Immediate Symptomatic Management

First-Line Analgesic/Antipyretic Therapy

• Acetaminophen 1000 mg every 4-6 hours (maximum 4000 mg/24 hours) is the preferred first-line agent for fever, sore throat, body aches, and headache due to its superior safety profile with no gastrointestinal bleeding risk, no renal toxicity, and no cardiovascular effects. 1
• Alternatively, ibuprofen 400-600 mg every 6-8 hours can be used for pain and fever control, though it carries higher risk of adverse effects compared to acetaminophen. 1, 2

Nasal Congestion and Rhinorrhea Management

• Nasal saline irrigation 2-3 times daily provides effective clearance of nasal secretions and reduces congestion with minimal risk. 1, 2
• First-generation antihistamines (e.g., pheniramine 25-50 mg three times daily) can reduce excessive secretions, sneezing, and postnasal drip, though they cause sedation and anticholinergic effects. 3, 2
• Oral decongestants (pseudoephedrine 30-60 mg every 4-6 hours) may be added for severe nasal congestion, but avoid in patients with hypertension, anxiety, cardiac arrhythmia, angina, cerebrovascular disease, bladder-neck obstruction, or glaucoma. 1, 2
• Topical nasal decongestants (oxymetazoline) can be used for severe congestion but strictly limit to 3-5 days maximum to prevent rebound congestion (rhinitis medicamentosa). 1, 2

Cough Management

• The combination of a first-generation antihistamine plus decongestant (e.g., brompheniramine with sustained-release pseudoephedrine) has been shown to decrease cough severity and hasten resolution of postnasal drip in viral upper respiratory infections. 3
• Naproxen 220-440 mg twice daily can favorably affect cough associated with the common cold. 3

Why Antibiotics Must Be Avoided

• Antibiotics provide zero benefit for viral infections, do not prevent complications (bacterial sinusitis, otitis media, or asthma exacerbation), and cause adverse effects in 40-43% of patients. 1, 2
• The presence of purulent (yellow-green) nasal discharge is a normal feature of viral inflammation reflecting neutrophil activity, not bacterial infection, and should never trigger antibiotic therapy. 3, 1
• Symptoms lasting fewer than 10 days without high fever or severe unilateral facial pain reliably indicate viral etiology—approximately 98-99.5% of acute rhinosinusitis cases are viral and resolve spontaneously within 7-10 days. 1

Expected Clinical Course and Patient Education

• Symptoms typically peak within 3 days and resolve within 10-14 days without specific treatment. 1, 2
• Fever, myalgia, and pharyngitis usually resolve after 5 days, while nasal congestion and cough may persist into the second or third week—this is normal and does not indicate bacterial infection. 3
• Approximately 25% of patients continue to have cough, postnasal drip, and throat clearing at day 14, which represents postinfectious cough rather than bacterial superinfection. 3

When to Reassess or Escalate Care

Return for reassessment if any of the following occur: 1, 2

• Symptoms persist ≥10 days without any improvement
• High fever ≥39°C (102.2°F) with purulent nasal discharge and facial pain for ≥3-4 consecutive days
• "Double-sickening" pattern: initial improvement followed by worsening symptoms
• Severe headache, visual changes, periorbital swelling, altered mental status, or cranial nerve deficits (red flags for complications such as orbital cellulitis or meningitis)

Only consider antibiotics if clear evidence of secondary bacterial infection develops meeting specific criteria for acute bacterial rhinosinusitis. 1

Common Pitfalls to Avoid

• Do not prescribe antibiotics based on symptom duration alone if less than 10 days—bacterial sinusitis cannot be diagnosed during the first week of symptoms. 3
• Do not order sinus imaging for uncomplicated cases—up to 87% of viral infections show sinus abnormalities on CT, leading to unnecessary interventions. 3, 1
• Do not extend topical decongestant use beyond 5 days, as this causes rebound congestion requiring prolonged therapy. 1
• Avoid decongestants and antihistamines in children under 3 years due to possible adverse effects. 1

Adjunctive Therapies with Limited Evidence

• Zinc lozenges (≥75 mg/day of zinc acetate or gluconate) started within 24 hours of symptom onset may reduce duration by 1-2 days, but weigh benefits against adverse effects (nausea, bad taste). 1
• Vitamin C and echinacea have no proven benefit for treating established viral upper respiratory infections. 1